Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CRISPR Therapeutics AG - Common Shares (NQ: CRSP ) 40.94 +0.46 (+1.14%) Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 759,869 Open 40.48 Bid (Size) 40.82 (1) Ask (Size) 40.94 (1) Prev. Close 40.48 Today's Range 39.80 - 41.02 52wk Range 39.41 - 91.10 Shares Outstanding 78,935,098 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? December 22, 2024 Via The Motley Fool 1 big new Green Flag for CRISPR Therapeutics' Stock December 20, 2024 Via The Motley Fool Performance YTD -38.03% -38.03% 1 Month -18.77% -18.77% 3 Month -10.84% -10.84% 6 Month -27.71% -27.71% 1 Year -37.33% -37.33% More News Read More Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? December 20, 2024 Via Investor's Business Daily 2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? December 17, 2024 Via The Motley Fool 3 Things You Need to Know if You Buy CRISPR Therapeutics Today December 14, 2024 Via The Motley Fool 2 Biotech Stocks to Buy Hand Over Fist in December December 07, 2024 Via The Motley Fool Where Will CRISPR Therapeutics Be in 3 Years? November 15, 2024 Via The Motley Fool 3 of the Best Growth Stocks You Can Buy for Less than $100 December 05, 2024 Via The Motley Fool Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65% November 30, 2024 Via The Motley Fool Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments November 29, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? November 26, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts November 25, 2024 Via Benzinga Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? November 24, 2024 Via The Motley Fool 3 Monster Stocks in the Making November 23, 2024 Via The Motley Fool Deciphering Disruption: Inside Cathie Wood's Latest Plays November 16, 2024 Via MarketBeat Topics Artificial Intelligence ETFs Exposures Artificial Intelligence 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More November 16, 2024 Via The Motley Fool 3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029 November 13, 2024 Via The Motley Fool Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought November 08, 2024 Via The Motley Fool Smaller Cap Biotechs Are In Season: How Are We Doing? November 07, 2024 Via Talk Markets 3 Companies Building Tomorrow's Game-Changing Technologies November 05, 2024 Via The Motley Fool Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers November 02, 2024 Via The Motley Fool Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 October 31, 2024 Via Benzinga Topics ETFs Stocks Exposures US Equities 12 High-Growth Stocks That Could Deliver Parabolic Returns October 28, 2024 Via The Motley Fool The Ultimate Biotech Stock to Buy With $50 Right Now October 26, 2024 Via The Motley Fool Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought October 22, 2024 Via The Motley Fool Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
